Roberto Gonzalez 공개
[search 0]

Download the App!

show episodes
 
Loading …
show series
 
Dr Roy Herbst from the Yale Cancer Center discusses the clinical data on and optimal use of adjuvant osimertinib for patients with resected non-small cell lung cancer and an EGFR mutation. CME information and select publications here.저자 Research To Practice
 
Dr Laurie Sehn from the BC Cancer Center for Lymphoid Cancer in Vancouver, Canada, discusses the latest clinical research findings on non-Hodgkin and Hodgkin lymphomas from the 2020 ASH Annual Meeting. CME information and select publications here.저자 Research To Practice
 
Dr Natalie Callander from the University of Wisconsin Carbone Cancer Center discusses key presentations on multiple myeloma, Waldenström macroglobulinemia and amyloidosis from the 2020 ASH Annual Meeting. CME information and select publications here.저자 Research To Practice
 
Dr Roberto Iacovelli from the Fondazione Policlinico Universitario A Gemelli in Rome discusses the spectrum and management of side effects with hormonal therapies in prostate cancer. CME information and select publications here.저자 Research To Practice
 
Dr Harry Erba from Duke University in Durham, North Carolina, discusses key presentations on acute myeloid leukemia and myelodysplastic syndromes from the 2020 AS Annual Meeting. CME information and select publications here.저자 Research To Practice
 
Dr Manmeet Ahluwalia from the Miami Cancer Institute of Baptist Health South Florida discusses recently published and emerging research on the management of CNS metastases in patients with non-small cell lung cancer. CME information and select publications here.저자 Research To Practice
 
Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York discusses recently published and emerging research on the treatment of diffuse large B-cell lymphoma. CME information and select publications here.저자 Research To Practice
 
Dr Andrew Wei from the Alfred Hospital and Monash University in Melbourne, Australia, discusses recently published and emerging research on the treatment of acute myeloid leukemia not eligible for intensive induction therapy. CME information and select publications here.저자 Research To Practice
 
Dr Zofia Piotrowska from the Massachusetts General Hospital in Boston discusses emerging strategies for patients with non-small cell lung cancer and EGFR exon 20 insertion mutations. CME information and select publications here.저자 Research To Practice
 
Dr Mark Pegram from the Stanford University School of Medicine discusses the latest clinical data on and optimal use of newly approved therapies for HER2-positive metastatic breast cancer. CME information and select publications here.저자 Research To Practice
 
Dr Shaji Kumar from the Mayo Clinic in Rochester, Minnesota, and Dr Philip Thompson from the University of Texas MD Anderson Cancer Center discuss the role of minimal residual disease assessment in the management of multiple myeloma and chronic lymphocytic leukemia. CME information and select publications here.…
 
Dr Ann LaCasce from the Dana-Farber Cancer Institute discusses key presentations on chronic lymphocytic leukemia and follicular lymphoma from the 2020 ASH Annual Meeting. CME information and select publications here.저자 Research To Practice
 
Dr Kathleen Moore from the University of Oklahoma Health Sciences Center discusses key 2020 presentations on the role of PARP inhibitors and other treatment strategies in the management of advanced ovarian cancer. CME information and select publications here.저자 Research To Practice
 
Dr Aaron Gerds from the Cleveland Clinic Taussig Cancer Institute discusses key presentations on myeloproliferative neoplasms from the 2020 ASH Annual Meeting. CME information and select publications here.저자 Research To Practice
 
Dr Matthew Galsky from the Icahn School of Medicine at Mount Sinai in New York discusses recently published and emerging data on newly approved agents for urothelial bladder carcinoma. CME information and select publications here저자 Research To Practice
 
Dr Corey Langer from the Abramson Cancer Center at the University of Pennsylvania discusses recently published and emerging data on the role of immune checkpoint inhibitors in the treatment of metastatic non-small cell lung cancer without actionable mutations. CME information and select publications here…
 
Dr Sagar Lonial from the Winship Cancer Institute in Atlanta, Georgia, discuses key presentations on the management of multiple myeloma from the 2020 ASH Annual Meeting. CME information and select publications here저자 Research To Practice
 
Dr David Quinn from the University of Southern California in Los Angeles discusses the impact of COVID-19 on the management of cancer and the current challenges he is experiencing as a physician caring for patients at the front line of the pandemic. Additional resources Lee LYW et al. COVID-19 mortality in patients with cancer on chemotherapy or ot…
 
Dr Stephen Liu from Georgetown University Hospital in Washington, DC, discusses recently published and emerging research on the role of immunotherapy combination approaches in the treatment of metastatic non-small cell lung cancer. CME information and select publications here.저자 Research To Practice
 
Dr David O’Malley from the Ohio State University and The James Cancer Center in Columbus discusses the current and future roles of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers. CME information and select publications here.저자 Research To Practice
 
Dr Philip A Philip from the Karmanos Cancer Institute in Detroit, Michigan, discusses recent data sets in gastrointestinal cancers from the ASCO and ESMO 2020 meetings that are most likely to have an impact on clinical practice. Faculty information and select publications here.저자 Research To Practice
 
Dr Eric Klein from the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio, discusses the role of liquid biopsy for cancer detection, including his experience with the Circulating Cell-Free Genome Atlas study. Faculty information and select publications here.저자 Research To Practice
 
Professor Stephen Johnston from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London discusses the role of CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer. CME information and select publications here.저자 Research To Practice
 
Dr Ross Camidge from the University of Colorado in Denver discusses recently published and emerging research in the management of non-small cell lung cancer with ALK and ROS1 rearrangements. CME information and select publications here.저자 Research To Practice
 
Dr Ashish Kamat from the University of Texas MD Anderson Cancer Center in Houston discusses recently published and emerging research on the use of immune checkpoint inhibitors and other novel therapies for patients with urothelial bladder cancer. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Keith Pratz from the University of Pennsylvania in Philadelphia to discuss recently published and emerging research in the use of FLT3 inhibitors for patients with acute myeloid leukemia. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Tanya Siddiqi from the City of Hope National Medical Center in Duarte, California, to discuss recently published and emerging research in the use of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr Kim Reiss Binder from the Abramson Cancer Center in Philadelphia to discuss recently published and emerging research on the use of PARP inhibitors in pancreatic cancer. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Courtney DiNardo from the MD Anderson Cancer Center in Houston, Texas, to discuss recently published and emerging research on the management of acute myeloid leukemia not eligible for intensive induction therapy. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr John Pagel from the Swedish Cancer Institute in Seattle to discuss recently published and emerging research in the front-line treatment of chronic lymphocytic leukemia. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Jeffrey Lancet from the Moffitt Cancer Center in Tampa, Florida, to discuss recently published and emerging research on induction and maintenance strategies for patients with acute myeloid leukemia. CME information and select publications here.…
 
Loading …

빠른 참조 가이드

Google login Twitter login Classic login